Vernalis Research

Vernalis Research develops and applies fragment-based and structure-based approaches to address challenges in drug discovery. We have the experience and capability to advance projects from concept to clinic. We have generated lead compounds on enzymes, protein-protein interactions, and GPCRs, providing preclinical candidates for numerous targets across various therapeutic areas.